Impact of hypertension on clinical outcome in STEMI patients undergoing primary angioplasty with BMS or DES: Insights from the DESERT cooperation

International Journal of Cardiology

Volumn 175, Issue 1, 2014, Pages 50-54

  De Luca, Giuseppe ^a,b   Dirksen, Maurits T ^c   Spaulding, Christian ^d   Kelbæk, Henning ^e   Schalij, Martin ^f   Thuesen, Leif ^g   Van Der Hoeven, Bas ^f   Vink, Marteen A ^c   Kaiser, Christoph ^h   Musto, Carmine ⁱ   Chechi, Tania ^j   Spaziani, Gaia ^j   Diaz De La Llera, Luis Salvador ^k   Pasceri, Vincenzo ^l   Di Lorenzo, Emilio ^m   Violini, Roberto ⁱ   Suryapranata, Harry ⁿ   Stone, Gregg W ^o,p  

^a MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e University of Copenhagen   (Denmark)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g AARHUS UNIVERSITY HOSPITAL   (Denmark)

^h UNIVERSITY HOSPITAL BASEL   (Switzerland)

ⁱ SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^j SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^k HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^l SAN FILIPPO NERI HOSPITAL   (Italy)

^m Division of Cardiology   (Italy)

ⁿ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^o Department of Medicine   (United States)

^p CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

more..

Author keywords

BMS; DES; Hypertension; Primary angioplasty; ST elevation myocardial infarction

Indexed keywords

ADULT; AGING; ANGIOPLASTY; ARTICLE; BARE METAL STENT; CARDIOVASCULAR MORTALITY; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; GENDER; HEART INFARCTION; HEART REINFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVASCULARIZATION; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TARGET VESSEL REVASCULARIZATION; AGED; META ANALYSIS; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; TRENDS;

METAL;

AGED; ANGIOPLASTY, BALLOON, CORONARY; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84902547390     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.04.180     Document Type: Article

References (29)

1. G. De Luca, E. Cassetti, and P. Marino Percutaneous coronary intervention-related time delay, patient's risk profile, and survival benefits of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction Am J Emerg Med 27 2009 712 719
2. G. De Luca, G. Biondi-Zoccai, and P. Marino Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials Ann Emerg Med 52 2008 665 676
3. G.W. Stone, B. Witzenbichler, and G. Guagliumi et al. Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230
4. G. De Luca, E. Cassetti, M. Verdoia, and P. Marino Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty: a meta-analysis of randomised trials Thromb Haemost 102 2009 428 436
5. G. De Luca, F. Bellandi, and K. Huber et al. Early glycoprotein IIb-IIIa inhibitors in primary angioplasty-abciximab long-term results (EGYPT-ALT) cooperation: individual patient's data meta-analysis J Thromb Haemost 9 2011 2361 2370
6. E. Di Lorenzo, G. De Luca, and R. Sauro et al. The PASEO (paclitaxel or sirolimus-eluting stent versus bare metal stent in primary angioplasty) randomized trial JACC Cardiovasc Interv 2 2009 515 523
7. G. De Luca, E.P. Navarese, and H. Suryapranata A meta-analytic overview of thrombectomy during primary angioplasty Int J Cardiol 166 2012 606 612
8. C.O. Costantini, G.W. Stone, and R. Mehran et al. Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction J Am Coll Cardiol 44 2004 305 312
9. G. De Luca, A.W. van 't Hof, and J.P. Ottervanger et al. Unsuccessful reperfusion in patients with ST-segment elevation myocardial infarction treated by primary angioplasty Am Heart J 150 2005 557 562
10. D. Levy, P.W. Wilson, K.M. Anderson, and W.P. Castelli Stratifying the patient at risk from coronary disease: new insights from the Framingham Heart Study Am Heart J 119 1990 712 717
11. S.W. Rabkin, F.A.L. Mathewson, and R.B. Tate Prognosis after acute myocardial infarction: relation to blood pressure values before infarction in a prospective cardiovascular study Am J Cardiol 40 1977 604 610
12. C. Fresco, F. Avanzini, and S. Bosi et al. Prognostic value of a history of hypertension in 11,483 patients with acute myocardial infarction treated with thrombolysis. GISSI-2 Investigators. Gruppo Italiano per lo Studio della, Sopravvivenza nell'Infarto Miocardico J Hypertens 14 1996 743 750
13. P.E. Aylward, R.G. Wilcox, and J.H. Horgan et al. Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators Ann Intern Med 125 1996 891 900
14. S.K. Majahalme, D.E. Smith, and J.V. Cooper et al. Comparison of patients with acute coronary syndrome with and without systemic hypertension Am J Cardiol 92 2003 258 263
15. M. Jonas, E. Grossman, V. Boyko, S. Behar, H. Hod, and H. Reicher-Reiss Relation to early and one-year outcome after acute myocardial infarction to systemic arterial blood pressure on admission Am J Cardiol 84 1999 162 165
16. A.M. Richards, M.G. Nicholls, and R.W. Troughton et al. Antecedent hypertension and heart failure after myocardial infarction J Am Coll Cardiol 39 2002 1182 1188
17. M. Rembek, A. Goch, and J. Goch The clinical course of acute ST-elevation myocardial infarction in patients with hypertension Kardiol Pol 68 2010 157 163
18. M.G. Abrignani, L.J. Dominguez, and G. Biondo et al. In-hospital complications of acute myocardial infarction in hypertensive subjects Am J Hypertens 18 2005 165 170
19. G. Parodi, N. Carrabba, and G.M. Santoro et al. Heart failure and left ventricular remodeling after reperfused acute myocardial infarction in patients with hypertension Hypertension 47 2006 706 710
20. C. Lazzeri, S. Valente, M. Chiostri, P. Attanà, C. Picariello, and G.F. Gensini Impact of hypertension on short- and long-term prognoses in patients with ST elevation myocardial infarction and without previously known diabetes Heart Vessels 27 2012 370 376
21. E. Cecchi, M.G. D'Alfonso, and M. Chiostri et al. Impact of hypertension history on short and long-term prognosis in patients with acute myocardial infarction treated with percutaneous angioplasty: comparison between STEMI and NSTEMI High Blood Press Cardiovasc Prev 21 Nov 2014 37 43
22. M.G. Lee, M.H. Jeong, and K.H. Lee et al. Prognostic impact of diabetes mellitus and hypertension for mid-term outcome of patients with acute myocardial infarction who underwent percutaneous coronary intervention J Cardiol 60 2012 257 263
23. G. De Luca, M.T. Dirksen, and C. Spaulding et al. Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials Arch Intern Med 172 2012 611 621
24. G. De Luca, A.W. van't Hof, and K. Huber et al. Impact of hypertension on distal embolization, myocardial perfusion, and mortality in patients with ST segment elevation myocardial infarction undergoing primary angioplasty Am J Cardiol 112 2013 1083 1086
25. G. De Luca, N. Ernst, and A.W. van 't Hof et al. Predictors and clinical implications of early reinfarction after primary angioplasty for ST-segment elevation myocardial infarction Am Heart J 151 2006 1256 1259
26. G. De Luca, M.T. Dirksen, and C. Spaulding et al. Time course, predictors and clinical implications of stent thrombosis following primary angioplasty. Insights from the DESERT cooperation Thromb Haemost 110 2013 826 833
27. E.P. Navarese, J. Kubica, and F. Castriota et al. Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials EuroIntervention 7 2011 985 994
28. L. Räber, H. Kelbæk, and M. Ostojic et al. Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial JAMA 308 2012 777 787
29. M. Sabate, A. Cequier, and A. Iñiguez et al. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial Lancet 380 2012 1482 1490